Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Refereed |
Title | Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment. |
Journal | Formal name:Clinical Lymphoma Myeloma and Leukemia |
Domestic / Foregin | Foregin |
Volume, Number, Page | 18(5),pp.353-360 |
Papers・Author | Okada Masaya,Imagawa Jun,Tanaka Hideo,Nakamae Hirohisa,Hino Masayuki, Murai Kazunori,Ishida Yoji,Kumagai Takashi,Sato Seiichi,Ohashi Kazuteru , Sakamaki Hisashi,Wakita Hisashi,Uoshima Nobuhiko,Nakagawa Yasunori, Minami Yosuke,Ogasawata Masahiro,Takeoka Tomoharu,Akasaka Hiroshi, Utsumi Takahiko,Uike Naokuni,Sato Tsutomu,Ando Sachiko,Usuki Kensuke,Mizuta Syuichi,Hashino Satoshi,Nomura Tetsuhiko,Shikami Masato,Fukutani Hisashi ,Ohe Yokiko,Kosugi Hiroshi,Shibayama Hirohiko,Maeda Yasuhiro, Fukushima Toshihiro,Yamazaki Hirohito,Tsubaki Kazuo,Kukita Toshimasa,Adachi Yoko,Nataduka Toshiki,Sakoda Hiroto,Yokoyama Hisayuki,Okamoto Takahiro,Shirasugi Yukari,Onishi Yasushi,Nohgawa Masaharu,Yoshihara Satoshi,Morita Satoshi,Sakamoto Junichi,Kimura Shinya |
Publication date | 2018/05 |